...
首页> 外文期刊>Clinical and Experimental Immunology: An Official Journal of the British Society for Immunology >Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
【24h】

Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.

机译:同种异体骨髓移植加成年胸腺移植治疗MRL / lpr小鼠自身免疫性疾病。

获取原文
获取原文并翻译 | 示例

摘要

Summary MRL/lpr mice (H-2(k)) with Fas gene mutation develop severe autoimmune diseases, and their haematolymphoid cells such as bone marrow and spleen cells showed a low apoptotic activity by irradiation. Therefore, conventional bone marrow transplantation (BMT) cannot be used to treat autoimmune diseases in these mice (chimeric resistance). In the present study, we examine the effects of additional adult thymus transplantation (TT) from the same donor on successful BMT. When the MRL/lpr mice were lethally irradiated (9.5Gy) and reconstituted with 3 x 10(7) of C57BL/6 mouse (H-2(b)) bone marrow cells (BMCs) in conjunction with TT, the mice significantly survived long term and showed a high donor-derived chimerism in comparison with those treated with BMT alone. Interestingly, the numbers of not only donor-derived T cells but also B cells increased significantly in the mice treated with BMT plus TT, even at the early phase of BMT. The number of aberrant CD3(+)B220(+) cells decreased significantly, and the numbers of lymphocyte subsets were also normalized 4 weeks after the treatment. Finally, the autoimmune diseases in MRL/lpr mice could be cured by BMT with TT. These results indicate that the combination of BMT plus TT can overcome the chimeric resistance and treat the autoimmune diseases in MRL/lpr mice.
机译:总结具有Fas基因突变的MRL / lpr小鼠(H-2(k))会发展为严重的自身免疫疾病,并且它们的血淋巴样细胞(如骨髓和脾细胞)在辐射下显示出低凋亡活性。因此,常规的骨髓移植(BMT)不能用于治疗这些小鼠的自身免疫性疾病(嵌合抗性)。在本研究中,我们检查了来自同一供体的其他成人胸腺移植(TT)对成功BMT的影响。当对MRL / lpr小鼠进行致命的辐射(9.5Gy)并用3 x 10(7)的C57BL / 6小鼠(H-2(b))骨髓细胞(BMC)与TT重构时,这些小鼠显着存活与仅使用BMT进行治疗的患者相比,具有较高的供体衍生嵌合性。有趣的是,即使在BMT的早期阶段,用BMT加TT处理的小鼠中,不仅供体来源的T细胞而且B细胞的数量也显着增加。治疗后4周,异常的CD3(+)B220(+)细胞数量显着减少,淋巴细胞亚群的数量也恢复正常。最后,MRT / lpr小鼠的自身免疫性疾病可以通过BMT和TT治愈。这些结果表明,BMT + TT的组合可以克服MRL / lpr小鼠的嵌合抗性并治疗自身免疫性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号